279 related articles for article (PubMed ID: 29209123)
1. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
3. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
[No Abstract] [Full Text] [Related]
4. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
[TBL] [Abstract][Full Text] [Related]
5. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
6. Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma.
Yu MC; Wu TH; Lee CW; Lee YS; Lian JH; Tsai CL; Hsieh SY; Tsai CN
Biomed J; 2021 Dec; 44(6 Suppl 1):S73-S83. PubMed ID: 35747997
[TBL] [Abstract][Full Text] [Related]
7. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
[TBL] [Abstract][Full Text] [Related]
8. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
Wang D; Zhu ZZ; Jiang H; Zhu J; Cong WM; Wen BJ; He SQ; Liu SF
Hepatol Int; 2015 Jul; 9(3):438-46. PubMed ID: 26067772
[TBL] [Abstract][Full Text] [Related]
9. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
[TBL] [Abstract][Full Text] [Related]
10. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
11. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
[TBL] [Abstract][Full Text] [Related]
12. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of multiple allelic losses on metastatic recurrence in hepatocellular carcinoma after curative resection.
Nishida N; Fukuda Y; Komeda T; Ito T; Nishimura T; Minata M; Kuno M; Katsuma H; Ikai I; Yamaoka Y; Nakao K
Oncology; 2002; 62(2):141-8. PubMed ID: 11914600
[TBL] [Abstract][Full Text] [Related]
14. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.
Zhu ZZ; Bao LL; Zhao K; Xu Q; Zhu JY; Zhu KX; Wen BJ; Ye YQ; Wan XX; Wang LL; He SQ; Cong WM
Curr Med Sci; 2019 Oct; 39(5):759-765. PubMed ID: 31612394
[TBL] [Abstract][Full Text] [Related]
15. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
[TBL] [Abstract][Full Text] [Related]
17. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of FFPE based Wilms' Tumor samples through copy number and somatic mutation related Molecular Inversion Probe Based Array.
Singh N; Sahu DK; Goel M; Kant R; Gupta DK
Gene; 2015 Jul; 565(2):295-308. PubMed ID: 25913740
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]